The Pentagon has officially paused a recently introduced policy that mandated testosterone blood tests for active-duty and reserve male service members aged 30 and older. The guidance, which was intended to screen for testosterone deficiencies across the military, was rescinded on Thursday, just one day after it was first unveiled to the public.

According to a Pentagon official who spoke with The Hill, the decision to pull the guidance was immediate. While the policy was framed as a health screening measure, its rapid reversal suggests internal concerns regarding the implementation or the necessity of the testing protocol. The original guidance had distinguished between age groups, specifically targeting men over 30 for mandatory blood work, while setting different parameters for younger personnel.

As of now, the Department of Defense has not provided a detailed explanation for why the policy was introduced and subsequently withdrawn in such a short timeframe. The status of potential future screenings remains unclear, and it is unknown whether the Pentagon intends to revise the policy or abandon the mandatory testing requirement entirely. The abrupt nature of the rescission has left many questions regarding the medical rationale behind the initial mandate and the administrative process that led to its sudden cancellation.